Gholami_2023_Sci.Rep_13_643

Reference

Title : In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor - Gholami_2023_Sci.Rep_13_643
Author(s) : Gholami A , Minai-Tehrani D , Eriksson LA
Ref : Sci Rep , 13 :643 , 2023
Abstract : Gholami_2023_Sci.Rep_13_643
ESTHER : Gholami_2023_Sci.Rep_13_643
PubMedSearch : Gholami_2023_Sci.Rep_13_643
PubMedID: 36635365

Related information

Citations formats

Gholami A, Minai-Tehrani D, Eriksson LA (2023)
In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor
Sci Rep 13 :643

Gholami A, Minai-Tehrani D, Eriksson LA (2023)
Sci Rep 13 :643